WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 534649

CAS#: 1882-26-4

Description: Pyricarbate is a drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)

Chemical Structure

CAS# 1882-26-4

Theoretical Analysis

MedKoo Cat#: 534649
Name: Pyricarbate
CAS#: 1882-26-4
Chemical Formula: C11H15N3O4
Exact Mass: 253.1063
Molecular Weight: 253.258
Elemental Analysis: C, 52.17; H, 5.97; N, 16.59; O, 25.27

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Pyricarbate

IUPAC/Chemical Name: 2,6-Pyridinediyldimethylene bis(methylcarbamate)


InChi Code: InChI=1S/C11H15N3O4/c1-12-10(15)17-6-8-4-3-5-9(14-8)7-18-11(16)13-2/h3-5H,6-7H2,1-2H3,(H,12,15)(H,13,16)


Appearance: Solid powder

Purity: >98% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >3 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

Preparing Stock Solutions

The following data is based on the product molecular weight 253.258 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.


Dilution Calculator

Calculate the dilution required to prepare a stock solution.

1: Sée A, Bouvry M. Hépatite au pyricarbate [Hepatitis from pyricarbate]. Gastroenterol Clin Biol. 1984 Jun-Jul;8(6-7):579. French. PMID: 6745580.

2: Biour M, Barbare JC, Begaud B, Furet Y, Grange JD, Cheymol G. Hépatites aiguës dues au pyricarbate (Angioxine). A propos de 5 cas [Acute hepatitis due to pyricarbate (Angioxine). Apropos of 5 cases]. Therapie. 1984 Sep- Oct;39(5):531-6. French. PMID: 6506010.

3: Walton KW, Thomas C, Dunkerley DJ. The pathogenesis of xanthomata. J Pathol. 1973 Apr;109(4):271-89. doi: 10.1002/path.1711090402. PMID: 4578583.

4: Numano F. Chemotherapy of atherosclerosis. Jpn Circ J. 1980 Jan;44(1):55-68. doi: 10.1253/jcj.44.55. PMID: 6245288.

5: Apport de l'Angioxine dans la protection vasculaire du diabétique [Contribution of angioxine to the vascular protection of the diabetic]. Journ Annu Diabetol Hotel Dieu. 1976 May:319-27. French. PMID: 796526.

6: Romics L. Drug treatment of hyperlipoproteinaemia. Ther Hung. 1983;31(4):152-60. PMID: 6400456.

7: Sassard J, Bernard N, Legheand J, Cuisinaud G, Traeger J. Pharmacokinetics and bioavailability of pyridinol carbamate in humans. J Pharm Sci. 1979 Sep;68(9):1190-1. doi: 10.1002/jps.2600680939. PMID: 501551.

8: Szén T, Szöllösy A. Uber die Synthese von Pyridinolcarbamat [Synthesis of pyridinolcarbamate]. Arch Pharm (Weinheim). 1977 Sep;310(9):759-62. German. doi: 10.1002/ardp.19773100912. PMID: 921516.

9: Margolis MG. Angioprotektory v oftal'mologii [Angioprotectors in ophthalmology]. Oftalmol Zh. 1979;34(5):314-8. Russian. PMID: 503433.

10: Chekova LP, Trubnikov VI, Shemiakin FM. Rol' sorbentov v gazokhromatograficheskom analize geterotsiklicheskikh azotsoderzhashchikh lekarstvennykh veshchestv [Role of sorbents in the gas chromatographic analysis of heterocyclic nitrogen-containing drug substances]. Farmatsiia. 1975 Jul- Aug;24(4):77-84. Russian. PMID: 767148.